STOCK TITAN

Precision Optics COO receives 60,000-option inducement grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Precision Optics Corporation (POCI) disclosed a Form 4 showing an inducement stock option grant to its Chief Operating Officer. On October 1, 2025, the executive received options to purchase 60,000 shares of common stock at an exercise price of $4.34 per share.

The option vests in three equal annual installments beginning October 1, 2026, and expires on October 1, 2035. Following the grant, the reporting person beneficially owns 60,000 derivative securities, held directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
TRAUT JOSEPH

(Last) (First) (Middle)
C/O PRECISION OPTICS CORPORATION, INC.
22 EAST BROADWAY

(Street)
GARDNER MA 01440

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PRECISION OPTICS CORPORATION, INC. [ POCI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Rights to buy) $4.34 10/01/2025 A 60,000 (1) 10/01/2035 Common Stock 60,000 $0 60,000 D
Explanation of Responses:
1. On October 1, 2025, the Reporting Person was granted an inducment stock option to purchase 60,000 shares of Issuer's common stock that vests in three equal annual installments beginning on October 1, 2026. The inducment stock option is subject to a Stock Option Agreement by and between the Reporting Person and the Issuer.
/s/ Joseph N. Forkey as attorney-in-fact 11/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did POCI report in this Form 4 filing?

A 60,000-share inducement stock option grant to the Chief Operating Officer with a $4.34 exercise price.

When do the POCI options vest and expire?

They vest in three equal annual installments starting October 1, 2026, and expire on October 1, 2035.

What is the exercise price for the options reported by POCI?

The exercise price is $4.34 per share.

How many derivative securities does the reporting person own after the transaction?

The reporting person beneficially owns 60,000 derivative securities following the grant.

What is the purpose of the option grant disclosed by POCI?

It is an inducement stock option granted under a Stock Option Agreement between the executive and the company.

Is the ownership direct or indirect for the reported POCI options?

The ownership is reported as Direct (D).
Precision Optics

NASDAQ:POCI

POCI Rankings

POCI Latest News

POCI Latest SEC Filings

POCI Stock Data

32.79M
5.55M
18.29%
34.31%
0.71%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States
GARDNER